Exscientia

Developer of artificial intelligence software for identifying potential drug candidates

placeOxford, England, United Kingdom calendar_todayFounded 2012 language exscientia.com

Registered entities

Investor mix

17 investors on record; lead investors include Novo Holdings, BlackRock, GT Healthcare Capital Partners, Bristol-Myers Squibb.

Investor typeCountShare
Venture capital424%
Private equity16%
Bank & private debt16%
Other / undisclosed1165%
Coming soon